These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 28499525

  • 1. Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents.
    Tack LJW, Heyse R, Craen M, Dhondt K, Bossche HV, Laridaen J, Cools M.
    J Sex Med; 2017 May; 14(5):747-757. PubMed ID: 28499525
    [Abstract] [Full Text] [Related]

  • 2. Proandrogenic and Antiandrogenic Progestins in Transgender Youth: Differential Effects on Body Composition and Bone Metabolism.
    Tack LJW, Craen M, Lapauw B, Goemaere S, Toye K, Kaufman JM, Vandewalle S, T'Sjoen G, Zmierczak HG, Cools M.
    J Clin Endocrinol Metab; 2018 Jun 01; 103(6):2147-2156. PubMed ID: 29672753
    [Abstract] [Full Text] [Related]

  • 3. Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial.
    Burinkul S, Panyakhamlerd K, Suwan A, Tuntiviriyapun P, Wainipitapong S.
    J Sex Med; 2021 Jul 01; 18(7):1299-1307. PubMed ID: 34274044
    [Abstract] [Full Text] [Related]

  • 4. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
    Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K, Kaufman JM, T'Sjoen G.
    J Sex Med; 2014 Aug 01; 11(8):1999-2011. PubMed ID: 24828032
    [Abstract] [Full Text] [Related]

  • 5. Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women.
    Cunha FS, Domenice S, Sircili MHP, Mendonca BB, Costa EMF.
    Clinics (Sao Paulo); 2018 Aug 01; 73():e86. PubMed ID: 29723345
    [Abstract] [Full Text] [Related]

  • 6. Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women.
    Fung R, Hellstern-Layefsky M, Tastenhoye C, Lega I, Steele L.
    J Sex Med; 2016 Nov 01; 13(11):1765-1772. PubMed ID: 27693265
    [Abstract] [Full Text] [Related]

  • 7. Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis.
    Tack LJ, Craen M, Dhondt K, Vanden Bossche H, Laridaen J, Cools M.
    Biol Sex Differ; 2016 Nov 01; 7():14. PubMed ID: 26885361
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A systematic review of antiandrogens and feminization in transgender women.
    Angus LM, Nolan BJ, Zajac JD, Cheung AS.
    Clin Endocrinol (Oxf); 2021 May 01; 94(5):743-752. PubMed ID: 32926454
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes of Vitamin D-Binding Protein, and Total, Bioavailable, and Free 25-Hydroxyvitamin D in Transgender People.
    Chen H, Wiepjes CM, van Schoor NM, Heijboer AC, de Jongh RT, den Heijer M, Lips P.
    J Clin Endocrinol Metab; 2019 Jul 01; 104(7):2728-2734. PubMed ID: 30785996
    [Abstract] [Full Text] [Related]

  • 19. Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care.
    van Velzen DM, Nota NM, Simsek S, Conemans EB, T'Sjoen G, den Heijer M.
    Eur J Endocrinol; 2020 Nov 01; 183(5):529-536. PubMed ID: 33071222
    [Abstract] [Full Text] [Related]

  • 20. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
    Vita R, Settineri S, Liotta M, Benvenga S, Trimarchi F.
    Maturitas; 2018 Jan 01; 107():92-96. PubMed ID: 29169588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.